Advertisement
Screener

INOGEN, INC. (INGN) Overview

INOGEN, INC. (INGN) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.14; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.30; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.20; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.15; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$4.83$5.30$5.82$6.40$7.03$7.722025-11-062026-11-06$4.00$6.32$9.98$15.75$24.88$39.292021-11-082026-11-06$4.00$9.47$22.40$53.03$125.51$297.072016-11-072026-11-06$4.00$9.47$22.40$53.03$125.51$297.072014-02-142026-11-06$4.00$9.47$22.40$53.03$125.51$297.072014-02-142026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$6.03
Previous close
$5.37
Change
$0.66
Change (%)
12.29%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

INGN
-19.78%
S&P 500
(m)

1 year

INGN
-33.53%
S&P 500
(m)

3 years

INGN
+3.27%
S&P 500
(m)

5 years

INGN
-87.82%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.14

-0.38-0.28-0.17-0.070.0431 Mar 2025: estimate (m); actual -0.2531 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.1530 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.2030 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.3031 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.1430 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.14(m)(m)
1 Jan 202631 Mar 2026(m)-0.30(m)(m)
1 Jul 202530 Sept 2025(m)-0.20(m)(m)
1 Apr 202530 Jun 2025(m)-0.15(m)(m)
1 Jan 202531 Mar 2025(m)-0.25(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.86

-4.50-3.40-2.30-1.20-0.1031 Dec 2021: estimate (m); actual -0.2831 Dec 2021(m)31 Dec 2022: estimate (m); actual -3.6731 Dec 2022(m)31 Dec 2023: estimate (m); actual -4.4231 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.5231 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.8631 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.86(m)(m)
1 Jan 202431 Dec 2024(m)-1.52(m)(m)
1 Jan 202331 Dec 2023(m)-4.42(m)(m)
1 Jan 202231 Dec 2022(m)-3.67(m)(m)
1 Jan 202131 Dec 2021(m)-0.28(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 83.53M ■ Earnings -3.85M — Profit margin -4.61%

-19.35M-12.5%18.62M10.7%56.58M33.8%94.55M57.0%30 Sept 2025: revenue 79.09M; earnings -5.29M; profit margin -6.69%30 Sept 202531 Dec 2025: revenue 68.57M*; earnings 38.37M*; profit margin 55.95%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 72.40M; earnings -8.32M; profit margin -11.50%31 Mar 202630 Jun 2026: revenue 83.53M; earnings -3.85M; profit margin -4.61%30 Jun 2026

31 Dec 2025 ■ Revenue 295.30M ■ Earnings 22.75M — Profit margin 7.70%

-38.47M6.7%94.03M18.4%226.52M30.0%359.01M41.7%31 Dec 2022: revenue 320.55M; earnings 83.77M; profit margin 26.13%31 Dec 202231 Dec 2023: revenue 251.61M; earnings 102.45M; profit margin 40.72%31 Dec 202331 Dec 2024: revenue 278.76M; earnings 35.89M; profit margin 12.87%31 Dec 202431 Dec 2025: revenue 295.30M; earnings 22.75M; profit margin 7.70%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$6.03(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$6.03High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning INGN

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$20.90M
Profit margin
6.88%
Return on assets · 12 month
6.99%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
314.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
346.27K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
3.27%*
Total return · month
-2.17%*
Total return · quarter
-22.21%*
Total return · half year
-12.92%*
Total return · year to date
-19.78%*
Total return · 1 year
-33.53%*
Total return · 3 years
3.27%*
Total return · 5 years
-87.82%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$303.59M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

INOGEN, INC. Overview

View more →

(m)

(m)

SEC CIK
1294133
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
500 CUMMINGS CENTER, SUITE 2800, BEVERLY, Massachusetts, 01915, United States
Fiscal year end
1231
Phone
805-562-0500

Similar stocks

Stock NameCountryMarket CapPE Ratio
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B